CAIRO: The Egyptian market will receive a new batch of the hepatitis C treatment medication Sovaldi next June after being manufactured locally, Youm 7 reported Sunday.
Pharmed Healthcare Executive Director, Mohamed Mabrouk, said that his firm will deliver 500,000 bottles after being manufactured with local chemical materials.
“This step will give the Egyptian market an unprecedented motive,” he said.
In September 2014, Egypt imported 225,000 bottles from the U.S., manufactured by the Gilead Science Company, and also a received a similar amount in March 2015.
Egypt has the highest rate of hepatitis C infection in the world, according to the United Nations Population Fund, according to which 14.7 percent of the population ages 15-49 have tested positive for the virus.
The Ministry of Health treated 150,000 patients last year, and has stated it plans to treat 250,000 to 300,000 patients.